In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.
By use of a high-performance liquid chromatographic procedure, phenacetin (acetophenetidin) and its O-de-ethylated metabolite paracetamol (acetaminophen), after hydrolysis of paracetamol conjugates, were simultaneously quantified in arterial plasma of both control and 3-methylcholanthrene-pretreated rats after the i.v., portal vein and intraduodenal administration of phenacetin. 3-Methylcholanthrene pretreatment resulted in enhanced phenacetin disposition as was shown from decreased plasma half-life time, decreased oral availability, increased clearance and a raise in metabolite levels. By constructing plasma concentration-time curves and determining the areas under the curves, it was possible to assess liver and gut wall first-pass metabolism. It is concluded that in 3-methylcholanthrene-pretreated rats the intestine contributes significantly, and predominantly over the liver, to phenacetin first-pass metabolism. In contrast, gut wall metabolism in control rats could not be demonstrated.
D000082:Acetaminophen / Q000097:blood; D000818:Animals; D001682:Biological Availability; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D008748:Methylcholanthrene / Q000008:administration & dosage*; D010615:Phenacetin / Q000097:blood*; D051381:Rats; D011919:Rats, Inbred Strains
D000082:Acetaminophen; D008748:Methylcholanthrene; D010615:Phenacetin